ACRV·004890109·US·equity·Healthcare - Biotechnology-Activist
ACRV (ACRIVON THERAPEUTICS INC) is held by 30 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($11.6M), WELLINGTON MANAGEMENT GROUP LLP ($1.2M), RENAISSANCE TECHNOLOGIES LLC ($1.1M). Net institutional sentiment: Mixed.
See how ACRV's score breaks down across 4 SEC sources
Showing 1-20 of 39
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer